Found 292 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Immunotherapy of Melanoma Patients
PHASE1The purpose of this study is to test whether vaccination with antigenic pep...
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth
NAThe goal of this clinical trial is to determine if a complex intervention c...
Location
The George Institute for Global Health
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
PHASE1Background:
* PSA (prostate specific antigen) is a protein found on normal...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
PHASE2The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Location
The Queen Elizabeth Hospital
Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth
PHASE3This trial will evaluate the impact of an integrated intervention of daily ...
Location
Multiple Locations
Testing the SurVaxM Vaccine for Lung Cancer Prevention
PHASE2This phase II trial tests how well a survivin peptide vaccine called SurVax...
Location
Rocky Mountain Regional VA Medical Center
Vaccine Therapy in Treating Patients With Melanoma
PHASE2RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
PHASE1This study evaluates whether it is safe to administer a peptide vaccine wit...
Location
Cancer Center at the University of Virginia
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
PHASE1This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Location
Krankenhaus Nordwest